Blindsight is an experimental medical device developed by Neuralink. It has received Breakthrough Device Designation from the US Food and Drug Administration. From Wikipedia
This funding follows successful brain-chip implants in three patients ahead of planned 2026 vision-restoring Blindsight trials
